Lista de obras - Tateaki Naito - Dominio Público Uruguay

18F-FDG uptake on PET could be a predictive marker of Excision Repair Cross-Complementation Group 1 (ERCC1) expression in patients with thoracic neoplasms? ⬇️

artículo científico publicado el 1 de enero de 2012

A Patient with a Massive Single Cardiac Metastasis of Lung Adenocarcinoma, Diagnosed via a Biopsy: A Case Report.

artículo científico publicado en 2018

A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.

artículo científico publicado en 2017

A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia

scientific article published on 15 August 2019

A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.

artículo científico publicado en 2019

Acquired immunodeficiency associated with thymoma: a case report

scientific article published on 02 August 2019

Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

artículo científico publicado en 2017

Cardiac Dysfunction Caused by Osimertinib.

artículo científico publicado en 2017

Characteristics of cellular composition in malignant pericardial effusion and its association with the clinical course of carcinomatous pericarditis.

artículo científico publicado en 2017

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older ⬇️

artículo científico publicado el 5 de diciembre de 2012

Crizotinib-induced simultaneous multiple cardiac toxicities.

artículo científico publicado en 2018

Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors ⬇️

artículo científico publicado el 31 de agosto de 2011

Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 27 de marzo de 2013

Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer ⬇️

artículo científico publicado el 1 de febrero de 2015

Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases ⬇️

artículo científico publicado el 27 de marzo de 2013

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports ⬇️

artículo científico publicado el 28 de febrero de 2011

Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review

artículo científico publicado en 2019

Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia

scientific article published on 01 July 2019

Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer

artículo científico publicado en 2018

Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: A retrospective study in Japan ⬇️

artículo científico publicado el 27 de octubre de 2012

Foreign Body Impaction in the Esophagus

artículo científico publicado en 2019

Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC

scientific article published on 01 October 2018

Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer

scientific article published on 05 December 2018

High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy.

artículo científico publicado en 2017

ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease

artículo científico publicado en 2018

Impact of Cancer Cachexia on Hospitalization-associated Physical Inactivity in Elderly Patients with Advanced Non-small-cell Lung Cancer

artículo científico publicado en 2018

Impact of Early Chemotherapy Resumption on the Outcome after Staphylococcus aureus Bacteremia in Patients with Solid Tumors: A Retrospective Study in a Single Tertiary Cancer Center in Japan

artículo científico publicado en 2023

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy

artículo científico publicado en 2018

Intestinal metastasis from non-small-cell lung cancer initially detected by 18F-fluorodeoxyglucose positron emission tomography ⬇️

artículo científico publicado el 27 de noviembre de 2010

Microcavity Array System for Size-Based Enrichment of Circulating Tumor Cells from the Blood of Patients with Small-Cell Lung Cancer ⬇️

artículo científico publicado el 6 de junio de 2013

Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer

artículo científico publicado en 2017

Phase I Results of Vinorelbine With Concurrent Radiotherapy in Elderly Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI) ⬇️

artículo científico publicado el 27 de mayo de 2011

Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung ⬇️

artículo científico publicado el 20 de enero de 2013

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4) ⬇️

artículo científico publicado el 10 de noviembre de 2011

Phase I study of highly selective inhibitor of VEGFR tyrosine kinase, tivozanib, in Japanese patients with solid tumors ⬇️

artículo científico publicado el 21 de junio de 2013

Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status

scientific article published on 26 January 2019

Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer ⬇️

artículo científico publicado el 1 de marzo de 2012

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study ⬇️

artículo científico publicado el 23 de julio de 2013

Progress in multimodal intervention for cancer cachexia

artículo científico publicado en 2017

Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program

scientific article published on 01 October 2018

Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer ⬇️

artículo científico publicado el 8 de septiembre de 2010

Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System ⬇️

artículo científico publicado el 28 de junio de 2013

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2017

Skeletal muscle loss and prognosis of breast cancer patients

artículo científico publicado en 2017

The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer ⬇️

artículo científico publicado el 1 de julio de 2011

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors ⬇️

artículo científico publicado el 14 de febrero de 2013

The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.

artículo científico publicado en 2017

The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy ⬇️

artículo científico publicado el 23 de febrero de 2012

Thenar muscle metastasis as recurrence of pulmonary squamous cell carcinoma ⬇️

artículo científico publicado el 24 de enero de 2011

Tracheal granuloma 7 years after extubation.

artículo científico publicado en 2017

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer

scientific article published on 10 December 2020

Well-differentiated Hepatocellular Carcinoma Showing Intrahepatic Neural Invastion: Autopsied Case ⬇️

artículo científico publicado el 1 de abril de 1991

[Hurdles in Future Clinical Trials for Cancer Cachexia]

artículo científico publicado en 2019

Lista de obras de Tateaki Naito

18F-FDG uptake on PET could be a predictive marker of Excision Repair Cross-Complementation Group 1 (ERCC1) expression in patients with thoracic neoplasms? ⬇️

A Patient with a Massive Single Cardiac Metastasis of Lung Adenocarcinoma, Diagnosed via a Biopsy: A Case Report.

A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.

A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia

A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.

Acquired immunodeficiency associated with thymoma: a case report

Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

Cardiac Dysfunction Caused by Osimertinib.

Characteristics of cellular composition in malignant pericardial effusion and its association with the clinical course of carcinomatous pericarditis.

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older ⬇️

Crizotinib-induced simultaneous multiple cardiac toxicities.

Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors ⬇️

Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non–Small-Cell Lung Cancer ⬇️

Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer ⬇️

Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases ⬇️

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports ⬇️

Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review

Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia

Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer

Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: A retrospective study in Japan ⬇️

Foreign Body Impaction in the Esophagus

Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC

Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer

High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy.

ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease

Impact of Cancer Cachexia on Hospitalization-associated Physical Inactivity in Elderly Patients with Advanced Non-small-cell Lung Cancer

Impact of Early Chemotherapy Resumption on the Outcome after Staphylococcus aureus Bacteremia in Patients with Solid Tumors: A Retrospective Study in a Single Tertiary Cancer Center in Japan

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy

Intestinal metastasis from non-small-cell lung cancer initially detected by 18F-fluorodeoxyglucose positron emission tomography ⬇️

Microcavity Array System for Size-Based Enrichment of Circulating Tumor Cells from the Blood of Patients with Small-Cell Lung Cancer ⬇️

Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer

Phase I Results of Vinorelbine With Concurrent Radiotherapy in Elderly Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI) ⬇️

Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung ⬇️

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4) ⬇️

Phase I study of highly selective inhibitor of VEGFR tyrosine kinase, tivozanib, in Japanese patients with solid tumors ⬇️

Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status

Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer ⬇️

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study ⬇️

Progress in multimodal intervention for cancer cachexia

Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program

Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer ⬇️

Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System ⬇️

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.

Skeletal muscle loss and prognosis of breast cancer patients

The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer ⬇️

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors ⬇️

The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.

The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy ⬇️

Thenar muscle metastasis as recurrence of pulmonary squamous cell carcinoma ⬇️

Tracheal granuloma 7 years after extubation.

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer

Well-differentiated Hepatocellular Carcinoma Showing Intrahepatic Neural Invastion: Autopsied Case ⬇️

[Hurdles in Future Clinical Trials for Cancer Cachexia]